Epigenetic Inactivation of Tumor Suppressor Genes in Hematologic Malignancies
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-08-15
著者
-
Kinoshita Tomohiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kinoshita Tomohiro
Department Of Hematology Nagoya University Graduate School Of Medicine
-
KINOSHITA Tomohiro
Department of Hematology and Cell Therapy, Aichi Cancer Center
関連論文
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Epigenetic Inactivation of Tumor Suppressor Genes in Hematologic Malignancies
- Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity : A multicenter, retrospective analysis in Japan
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Castleman-Kojima Disease (TAFRO Syndrome) : A Novel Systemic Inflammatory Disease Characterized by a Constellation of Symptoms, Namely, Thrombocytopenia, Ascites (Anasarca), Microcytic Anemia, Myelofibrosis, Renal Dysfunction, and Organomegaly : A Statu